John Colvard

About John Colvard

Highly accomplished biotech sales professional with 21+ years of expertise with rare /…

Experience

1. Senior Clinical Account Manager

   Travere Therapeutics

   Aug 2014 — Present · Atlanta, GA, US

   Part of a new start-up rare disease sales team that successfully launched and profitably grew 3 orphan drugs:FIlspari – the first FDA-approved dual endothelin angiotensin receptor antagonist for IgA Nephropathy, a rare kidney disease.Cholbam - the first FDA-approved cholic acid replacement therapy for Bile Acid Synthesis Disorders due to single enzyme defects, an ultra-rare genetic disorder.Thiola – the first FDA-approved treatment for cystinuria, an ultra-rare autosomal recessive metabolic kidney disorder. Responsible for promoting products to academic institutions, pediatric & adult nephrologists and urologists, geneticists, pediatric hepatologists & gastroenterologists as well as pediatric & adult neurologists in GA, AL & FL. Ranked #1 of 24 CAMs in 2016 and earned the Capstone Award (President’s Club) for overall performance with Thiola and Cholbam new patient starts and total volume increase. Earned the 2016 Cholbam Brand Champion Award for being 1st in nation with 4 patient starts that generated $2 million.

Skills

• Pharmaceutical Sales
• Dermatology
• Oncology
• Urology
• Strategy
• Sales Effectiveness
• Biopharmaceuticals
• Cardiology
• Hospital Sales
• Hospitals
• Crm
• Budgets
• Lifesciences
• Sales Management
• Capital Equipment
• Infectious Diseases
• Medical Devices
• Biotechnology
• Market Access
• Sales Operations
• Commercialization
• Pulmonology
• Rheumatology
• Product Launch
• Gastroenterology
• Managed Care
• Leadership
• Account Management
• Pharmaceutical Industry
• Key Account Management
• Start-Ups
• Neurology
• Business Planning
• Clinical Trials
• Sales